Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
BALPHARMA Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Reasonable Debt to Equity, and decreasing
Consistently pays dividend
Negative
Weak price momentum
Low and declining ROE
Low but stable operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Neutral
Company's earnings are of moderate quality
Moderate dividend yield
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.052162.
Snapshot
See detailed analysis
BALPHARMA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
BALPHARMA Bulk, Block & Insider Trades
BALPHARMA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Rights issue(1 new shares @ 30 INR for 2 existing shares) Ex-date: 7th Apr 2005 Announced on: 4th Aug 2004
Company Profile
Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OT... Read More
Key personnel
Mr. Akash Mathur
Chief Executive Officer
Mr. Abdul Basith
Compliance Officer, Company Secretary
Shailesh D. SiroyaD
Managing Director, Executive Director
Sarika BhandariD
Additional Director
Mr. Ravindra Kumar KothariD
Non-Independent Non-Executive Director
Mr. Jatish ShethD
Additional Non-Executive Director
Ms. Nicola NeeladriD
Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Bal Pharma Ltd.?
The current share price of Bal Pharma Ltd. is ₹ 72.58 as of 09 Jan 2026.
What is the PE ratio of Bal Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Bal Pharma Ltd. is 16.91 as of the latest financial data.
What is the ROE and ROCE of Bal Pharma Ltd.?
Bal Pharma Ltd. has a Return on Equity (ROE) of 9.29% and a Return on Capital Employed (ROCE) of 7.67% as per the latest financial reports.
What is the market cap of Bal Pharma Ltd.?
The market capitalization of Bal Pharma Ltd. stands at ₹ 115.56 Cr.
What is the dividend yield of Bal Pharma Ltd.?
The dividend yield of Bal Pharma Ltd. is 1.65% based on the current market price.
What is the RSI of Bal Pharma Ltd.?
The Relative Strength Index (RSI) of Bal Pharma Ltd. is 43.59.
What is the FII and DII holding in Bal Pharma Ltd.?
Foreign Institutional Investors (FII) hold 0.23% and Domestic Institutional Investors (DII) hold 0.00% of Bal Pharma Ltd. shares.
What sector does Bal Pharma Ltd. belong to?
Bal Pharma Ltd. operates in the Healthcare sector.
What is the beta of Bal Pharma Ltd. stock?
The beta of Bal Pharma Ltd. stock is 0.71, indicating its volatility relative to the broader market.
